Iron Deficiency Anemia Therapy

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,950	192 Pages	Global Industry Analysts	August, 2024	GJOB19123728

Best Price Guarantee
Price	from $4,950
Length	192 Pages
Publisher	Global Industry Analysts
Published Date	August, 2024
SKU	GJOB19123728

Iron Deficiency Anemia Therapy

Global Iron Deficiency Anemia Therapy Market to Reach US$23.9 Billion by 2030

The global market for Iron Deficiency Anemia Therapy estimated at US$14.4 Billion in the year 2023, is expected to reach US$23.9 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Oral Iron Therapy, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$11.1 Billion by the end of the analysis period. Growth in the Parenteral Iron Therapy segment is estimated at 8.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.8 Billion While China is Forecast to Grow at 11.0% CAGR

The Iron Deficiency Anemia Therapy market in the U.S. is estimated at US$3.8 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.8 Billion by the year 2030 trailing a CAGR of 11.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Iron Deficiency Anemia Therapy Market - Trends & Future Prospects

Why Is Iron Deficiency Anemia a Global Health Concern?

Iron deficiency anemia (IDA) is one of the most common nutritional deficiencies worldwide, affecting millions of people, particularly women, children, and the elderly. This condition occurs when the body lacks sufficient iron to produce hemoglobin, leading to fatigue, weakness, and other health complications. IDA is particularly prevalent in developing regions, where access to iron-rich foods and healthcare is limited. However, it is also a significant concern in developed countries, where dietary habits, chronic illnesses, and certain medications can contribute to iron deficiency. Addressing IDA is crucial for improving public health outcomes, as untreated anemia can lead to severe complications, including impaired cognitive function, reduced work capacity, and increased risk of maternal and infant mortality.

How Are Advances in Therapy Improving Outcomes for Iron Deficiency Anemia Patients?

Advances in iron deficiency anemia therapy are improving outcomes for patients by offering more effective and convenient treatment options. Traditional oral iron supplements, while widely used, can cause gastrointestinal side effects and are not always effective in restoring iron levels in patients with severe anemia or malabsorption issues. Recent developments in intravenous (IV) iron therapies provide an alternative for these patients, offering rapid replenishment of iron stores with fewer side effects. Additionally, new formulations of oral iron supplements with enhanced absorption and tolerability are becoming available, improving patient compliance and outcomes. The use of combination therapies, such as iron supplements with vitamin C or other enhancers of iron absorption, is also being explored to boost the efficacy of treatments.

What Challenges Are Hindering the Widespread Adoption of Advanced Iron Deficiency Anemia Therapies?

Despite the availability of advanced therapies, several challenges hinder their widespread adoption. One major challenge is the cost and accessibility of IV iron treatments, which can be expensive and require administration in a clinical setting. This limits their use to patients with severe anemia or those who do not respond to oral supplements. Additionally, there is a lack of awareness among patients and healthcare providers about the importance of early diagnosis and treatment of IDA, leading to delays in care. Another challenge is the variability in response to iron therapy, as some patients may not achieve the desired outcomes due to underlying conditions or poor adherence to treatment. Addressing these challenges requires targeted educational initiatives, improved access to affordable treatments, and ongoing research to optimize therapy regimens for different patient populations.

What Factors Are Driving the Growth of the Iron Deficiency Anemia Therapy Market?

The growth of the iron deficiency anemia therapy market is driven by several factors, including the increasing prevalence of anemia, advancements in treatment options, and greater awareness of the condition. The rising incidence of chronic diseases, such as kidney disease and inflammatory bowel disease, which can lead to anemia, is also contributing to the demand for effective therapies. Additionally, the growing focus on maternal and child health, particularly in developing regions, is driving the need for accessible and affordable iron supplements. The expansion of healthcare infrastructure and the availability of new treatment options, such as improved oral and IV iron formulations, are further supporting market growth. As awareness of IDA and its health implications increases, more individuals are seeking diagnosis and treatment, driving demand for a range of therapeutic options.

Select Competitors (Total 38 Featured) -

Allergan PLC
AMAG Pharmaceuticals, Inc.
Johnson & Johnson
Keryx Biopharmaceuticals, Inc.
Luitpold Pharmaceuticals, Inc.
Pharmacosmos A/S
Pieris Pharmaceuticals, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW: Influencer Market Insights; World Market Trajectories; Iron Deficiency Anemia Therapy – Global Key Competitors Percentage Market Share in 2024 (E); Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E); Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS: Rising Prevalence of Iron Deficiency Anemia Spurs Growth in Therapy Market; Advancements in Oral Iron Supplements Propel Innovation in Anemia Treatment; Growing Demand for Intravenous (IV) Iron Therapies Expands Addressable Market; Shift Towards Non-Invasive Treatment Options Strengthens Business Case for New Therapies; Increased Focus on Early Diagnosis and Screening Drives Adoption of Anemia Therapies; Technological Innovations in Drug Delivery Systems Accelerate Demand for Advanced Therapies; Rising Awareness Campaigns on Iron Deficiency Throws Spotlight on Treatment Options; Expanding Applications of Iron Supplementation in Pregnant Women Generate New Opportunities; Shift Towards Personalized Medicine in Anemia Treatment Drives Market Innovation
4. GLOBAL MARKET PERSPECTIVE: TABLE 1: World Iron Deficiency Anemia Therapy Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030; TABLE 2: World Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR; TABLE 3: World Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 4: World 16-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030; TABLE 5: World Recent Past, Current & Future Analysis for Oral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR; TABLE 6: World Historic Review for Oral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 7: World 16-Year Perspective for Oral Iron Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030; TABLE 8: World Recent Past, Current & Future Analysis for Parenteral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR; TABLE 9: World Historic Review for Parenteral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 10: World 16-Year Perspective for Parenteral Iron Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030; TABLE 11: World Recent Past, Current & Future Analysis for Red Blood Cell Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR; TABLE 12: World Historic Review for Red Blood Cell Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 13: World 16-Year Perspective for Red Blood Cell Transfusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS: UNITED STATES; Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E); TABLE 14: USA Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 15: USA Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 16: USA 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; CANADA; TABLE 17: Canada Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 18: Canada Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 19: Canada 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; JAPAN; Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E); TABLE 20: Japan Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 21: Japan Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 22: Japan 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; CHINA; Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E); TABLE 23: China Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 24: China Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 25: China 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; EUROPE; Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E); TABLE 26: Europe Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR; TABLE 27: Europe Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 28: Europe 16-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030; TABLE 29: Europe Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 30: Europe Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 31: Europe 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; FRANCE; Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E); TABLE 32: France Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 33: France Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 34: France 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; GERMANY; Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E); TABLE 35: Germany Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 36: Germany Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 37: Germany 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; ITALY; TABLE 38: Italy Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 39: Italy Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 40: Italy 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; UNITED KINGDOM; Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E); TABLE 41: UK Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 42: UK Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 43: UK 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; SPAIN; TABLE 44: Spain Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 45: Spain Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 46: Spain 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; RUSSIA; TABLE 47: Russia Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 48: Russia Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 49: Russia 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; REST OF EUROPE; TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 51: Rest of Europe Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 52: Rest of Europe 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; ASIA-PACIFIC; Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E); TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR; TABLE 54: Asia-Pacific Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 55: Asia-Pacific 16-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030; TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 57: Asia-Pacific Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 58: Asia-Pacific 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; AUSTRALIA; Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E); TABLE 59: Australia Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 60: Australia Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 61: Australia 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; INDIA; Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E); TABLE 62: India Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 63: India Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 64: India 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; SOUTH KOREA; TABLE 65: South Korea Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 66: South Korea Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 67: South Korea 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; REST OF ASIA-PACIFIC; TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 69: Rest of Asia-Pacific Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; LATIN AMERICA; Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E); TABLE 71: Latin America Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR; TABLE 72: Latin America Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 73: Latin America 16-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030; TABLE 74: Latin America Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 75: Latin America Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 76: Latin America 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; ARGENTINA; TABLE 77: Argentina Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 78: Argentina Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 79: Argentina 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; BRAZIL; TABLE 80: Brazil Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 81: Brazil Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 82: Brazil 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; MEXICO; TABLE 83: Mexico Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 84: Mexico Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 85: Mexico 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; REST OF LATIN AMERICA; TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 87: Rest of Latin America Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 88: Rest of Latin America 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; MIDDLE EAST; Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E); TABLE 89: Middle East Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR; TABLE 90: Middle East Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 91: Middle East 16-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030; TABLE 92: Middle East Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 93: Middle East Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 94: Middle East 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; IRAN; TABLE 95: Iran Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 96: Iran Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 97: Iran 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; ISRAEL; TABLE 98: Israel Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 99: Israel Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 100: Israel 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; SAUDI ARABIA; TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 102: Saudi Arabia Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 103: Saudi Arabia 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; UNITED ARAB EMIRATES; TABLE 104: UAE Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 105: UAE Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 106: UAE 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; REST OF MIDDLE EAST; TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 108: Rest of Middle East Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 109: Rest of Middle East 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030; AFRICA; Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E); TABLE 110: Africa Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR; TABLE 111: Africa Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR; TABLE 112: Africa 16-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2014, 2024 & 2030
IV. COMPETITION